
WAY Stock Forecast & Price Target
WAY Analyst Ratings
Bulls say
Waystar Holding Corp has demonstrated a robust revenue growth trajectory, achieving a compound annual growth rate (CAGR) of 16% since 2022, bolstered by a projected step-up in 2024 due to external events impacting the healthcare sector. The company's client base reflects a positive trend, as high-value customers recorded a quarter-over-quarter growth rate of 3.4% as of Q1 2025, contributing significantly to the overall revenue composition. Additionally, the increase in channel partner fees, which rose from 6.5% of revenue in 2022 to 7.1% in the first half of 2025, suggests a growing reliance on third-party software integrations that can enhance the company's market presence and revenue potential.
Bears say
Waystar Holding Corp is facing a negative outlook primarily due to declining revenue expectations, with a forecasted sequential decrease in 3Q revenue and flat 4Q revenue, exacerbated by low capital expenditures relative to revenue, which dropped from 2.7% to 2.1%. Additionally, EBITDA has significantly decreased from 6.4x at the end of 2023 to 2.2x at the end of 2Q, indicating pressure on profitability and operational efficiency. Moreover, concerns over potential cybersecurity breaches, as demonstrated by the cyberattack on Change Healthcare, could jeopardize client relationships and growth initiatives, further diminishing the company's financial stability.
This aggregate rating is based on analysts' research of Waystar Holding Corp and is not a guaranteed prediction by Public.com or investment advice.
WAY Analyst Forecast & Price Prediction
Start investing in WAY
Order type
Buy in
Order amount
Est. shares
0 shares